Suzanne Louise Bruhn - Insider Trading & Ownership

Location
C/O Aeglea Biotherapeutics, Inc., 901 S. Mopac Expressway, Suite 250, Austin, TX
Summary
The estimated net worth of Suzanne Louise Bruhn is at least $720K dollars as of August 5, 2025. Suzanne Louise Bruhn is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $527K. Suzanne Louise Bruhn is the Director of Vigil Neuroscience, Inc. and owns shares of Vigil Neuroscience, Inc. (VIGL) stock worth about $138K. Suzanne Louise Bruhn is the Director of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $55.7K.
Signature
/s/ Michael Cohen, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Suzanne Louise Bruhn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TVTX Travere Therapeutics, Inc. Director $527K May 15, 2025
VIGL Vigil Neuroscience, Inc. Director $138K Aug 5, 2025
PLRX PLIANT THERAPEUTICS, INC. Director $55.7K Jun 5, 2025
AVTX Avalo Therapeutics, Inc. Director Nov 10, 2021
MNMD Mind Medicine (MindMed) Inc. Director Jun 12, 2025

Insider Transactions Reported by Suzanne Louise Bruhn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.